137 related articles for article (PubMed ID: 1412813)
1. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
[No Abstract] [Full Text] [Related]
2. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
[No Abstract] [Full Text] [Related]
3. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
[No Abstract] [Full Text] [Related]
4. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
[No Abstract] [Full Text] [Related]
5. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
[No Abstract] [Full Text] [Related]
6. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
7. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
Amemiya H; Suzuki S; Hayashi R; Nakatani T
Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
[No Abstract] [Full Text] [Related]
8. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
[No Abstract] [Full Text] [Related]
9. Effectiveness of 15-deoxyspergualin on renal graft rejection.
Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
[No Abstract] [Full Text] [Related]
10. Histopathological classification and clinical effects of kidney transplant rejection treated with 15-deoxyspergualin.
Kyo M; Ichikawa Y; Fukunishi Y; Hanafusa T; Nagano S; Takahara S; Ishibashi M; Okuyama A; Ihara H; Fujimoto N
Transplant Proc; 1995 Feb; 27(1):1012-3. PubMed ID: 7878780
[No Abstract] [Full Text] [Related]
11. Immunosuppressive mechanisms and action of deoxyspergualin in experimental and clinical studies. Japanese Collaborative Transplant Study Group of NKT-01.
Amemiya H
Transplant Proc; 1995 Feb; 27(1):31-2. PubMed ID: 7879015
[No Abstract] [Full Text] [Related]
12. 15-Deoxyspergualin "rescue therapy" for methylprednisolone-resistant rejection of renal transplants as compared with anti-T cell monoclonal antibody (OKT3).
Okubo M; Tamura K; Kamata K; Tsukamoto Y; Nakayama Y; Osakabe T; Sato K; Go M; Kumano K; Endo T
Transplantation; 1993 Mar; 55(3):505-8. PubMed ID: 8456469
[TBL] [Abstract][Full Text] [Related]
13. Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
Fudaba Y; Fukuda Y; Yamamoto H; Ohdan H; Shintaku S; Shibata S; Miyata Y; Marubayashi S; Asahara T; Dohi K
Transplant Proc; 1998 Nov; 30(7):3582-3. PubMed ID: 9838569
[No Abstract] [Full Text] [Related]
14. Beneficial effects of 15-deoxyspergualin on late acute rejection occurring more than three months after renal transplantation.
Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
Transplant Proc; 1998 Aug; 30(5):2246-7. PubMed ID: 9723458
[No Abstract] [Full Text] [Related]
15. Usefulness of 15-deoxyspergualin for rejection in renal transplantation.
Kozaki K; Kozaki M; Nagao T
Transplant Proc; 1999; 31(1-2):1138-9. PubMed ID: 10083509
[No Abstract] [Full Text] [Related]
16. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
Amemiya H; Taguchi Y; Fukao K; Isono K; Omoto R; Ota K; Kosaki M; Takagi H; Oka T; Sonoda T
Transplant Proc; 1993 Feb; 25(1 Pt 1):730-3. PubMed ID: 8438462
[No Abstract] [Full Text] [Related]
17. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
[No Abstract] [Full Text] [Related]
18. Outline and long-term prognosis in 15-deoxyspergualin-treated cases. Japan Collaborative Transplant Study Group of NKT-01.
Amemiya H; Koyama I; Kyo M; Kozaki K; Yuzawa K; Sakamoto K; Kakefuda T
Transplant Proc; 1996 Jun; 28(3):1156-8. PubMed ID: 8658608
[No Abstract] [Full Text] [Related]
19. Further study of deoxyspergualin prophylaxis in living related renal transplantation.
Okazaki H; Sato T; Amada N
Transplant Proc; 1993 Feb; 25(1 Pt 1):772-3. PubMed ID: 8438475
[No Abstract] [Full Text] [Related]
20. Experience gained from the administration of 15-deoxyspergualin for recurrent graft rejection in kidney transplant recipients.
Takahara S; Jiang H; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1992 Aug; 24(4):1377-80. PubMed ID: 1496592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
